FR2868307B1 - Utilisation de beta-endorphine pour le traitement des rides - Google Patents

Utilisation de beta-endorphine pour le traitement des rides

Info

Publication number
FR2868307B1
FR2868307B1 FR0403420A FR0403420A FR2868307B1 FR 2868307 B1 FR2868307 B1 FR 2868307B1 FR 0403420 A FR0403420 A FR 0403420A FR 0403420 A FR0403420 A FR 0403420A FR 2868307 B1 FR2868307 B1 FR 2868307B1
Authority
FR
France
Prior art keywords
endorphine
wrinkles
beta
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0403420A
Other languages
English (en)
Other versions
FR2868307A1 (fr
Inventor
Antoine Gedouin
Romuald Vallee
Pierre Yves Morvan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe de Courtage et de Diffusion SAS CODIF International
Original Assignee
Societe de Courtage et de Diffusion SAS CODIF International
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Courtage et de Diffusion SAS CODIF International filed Critical Societe de Courtage et de Diffusion SAS CODIF International
Priority to FR0403420A priority Critical patent/FR2868307B1/fr
Publication of FR2868307A1 publication Critical patent/FR2868307A1/fr
Application granted granted Critical
Publication of FR2868307B1 publication Critical patent/FR2868307B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
FR0403420A 2004-04-01 2004-04-01 Utilisation de beta-endorphine pour le traitement des rides Expired - Lifetime FR2868307B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0403420A FR2868307B1 (fr) 2004-04-01 2004-04-01 Utilisation de beta-endorphine pour le traitement des rides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0403420A FR2868307B1 (fr) 2004-04-01 2004-04-01 Utilisation de beta-endorphine pour le traitement des rides

Publications (2)

Publication Number Publication Date
FR2868307A1 FR2868307A1 (fr) 2005-10-07
FR2868307B1 true FR2868307B1 (fr) 2008-03-14

Family

ID=34946086

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0403420A Expired - Lifetime FR2868307B1 (fr) 2004-04-01 2004-04-01 Utilisation de beta-endorphine pour le traitement des rides

Country Status (1)

Country Link
FR (1) FR2868307B1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2443388A (en) * 2006-10-30 2008-05-07 Reckitt & Colmann Prod Ltd Acne treatment
FR2975006B1 (fr) * 2011-05-09 2016-06-03 L'occitane (Losa) Composition cosmetique ou dermatologique a base d'extraits d'immortelle et son utilisation
DE202019005637U1 (de) * 2018-07-03 2021-04-15 Mary Kay, Inc. Topische Muskelentspannungszusammensetzungen und deren Verwendung
FR3090375B1 (fr) * 2018-12-21 2021-10-22 Basf Beauty Care Solutions France Sas Nouvelles utilisations cosmétiques et dermatologiques d’un extrait de Cistus monspeliensis
FR3129830A1 (fr) 2021-12-07 2023-06-09 Pierre Fabre Dermo-Cosmetique Extrait de Cistus monspeliensis et compositions le comprenant pour apaiser la peau
FR3135205A1 (fr) 2022-05-09 2023-11-10 Pierre Fabre Dermo-Cosmetique Extrait de cistus monspeliensis et compositions le comprenant pour favoriser la cicatrisation et la reparation des lesions cutanees

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885974A (en) * 1994-12-06 1999-03-23 Michael M. Danielov Therapeutic methods utilizing naturally derived bio-active complexes and delivery systems therefor
US6558695B2 (en) * 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
FR2811228B1 (fr) * 2000-07-07 2002-10-25 Lvmh Rech Utilisation d'oligosaccharides ou d'extraits de plantes en contenant comme agent cosmetique ou dermatologique notamment pour stimuler la production de beta-endorphine dans la peau
FR2819718B1 (fr) * 2001-01-22 2005-02-25 Codif Internat Sa Produit cosmetique
FR2829145B1 (fr) * 2001-08-29 2004-12-03 Occitane L Huile essentielle extraite helichrysum italicum, sa preparation et les compositions cosmetiques et dermatologiques la contenant
FR2842201B1 (fr) * 2002-06-18 2005-01-14 Probest Nouvel oligosaccharide, compositions cosmetiques et/ou dermatologiques en contenant et ses applications
DE20313959U1 (de) * 2003-09-05 2003-12-04 Block, Andreas Hautcreme

Also Published As

Publication number Publication date
FR2868307A1 (fr) 2005-10-07

Similar Documents

Publication Publication Date Title
FR2920305B1 (fr) Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR22C1033I1 (fr) Utilisation de dihydroimidazolones pour le traitement des chiens
FR2907011B1 (fr) Utilisation de la citrulline pour le traitement des etats de denutrition
FR2867961B1 (fr) Instrument retractable de traitement pour un endoscope
FR2915102B1 (fr) Utilisation d'un anticorps anti-cxcr4 pour le traitement du cancer
FR2882654B1 (fr) Utilisation de derives de la diosmetine pour le traitement et la prevention des pathologies thrombotiques
CY2200156T2 (el) Επεξεργασια λυματων
ATE521365T1 (de) Kinin-antagonisten zur behandlung von blasenfunktionsstörung
FR2912761B1 (fr) Tricot prothetique pour le traitement des prolapsus
FR2907677B1 (fr) Utilisation d'un copolymere bloc polysiloxane/polyuree pour le traitement des cheveux
EP1750513A4 (fr) Utilisation de ligands gpcr54 pour le traitement de l'infertilite
FR2919501B1 (fr) Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees
FR2897533B1 (fr) Agent oxydant pour le traitement des cheveux
ATE439843T1 (de) S-mirtazapin zur behandlung von hitzewallungen
FR2900341B1 (fr) Utilisation de ligands synthetiques multivalents de la nucleoline de surface pour le traitement du cancer
FR2860154B1 (fr) Composition pour le traitement de la mauvaise haleine
FR2899128B1 (fr) Utilisation de filtres de deleucocytation pour la purification de defensines
FR2902320B1 (fr) Utilisation de butylated hydroxyanisole pour le traitement de la canitie
FR2889518B1 (fr) Systeme pour le traitement des eaux usees domestiques
FR2868307B1 (fr) Utilisation de beta-endorphine pour le traitement des rides
FR2910813B1 (fr) Nouvelle utilisation therapeutique pour le traitement des leucemies
FR2915098B1 (fr) Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere
FR2868312B1 (fr) Patch pour le traitement des levres
FR2887456B1 (fr) "composition pour le traitement de la dermite estivale"
FR2867073B1 (fr) Utilisation cosmetique de chitosane pour le traitement et le comblement des rides

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20